April 21, 2021
Updates to State Price Transparency Reporting, Medicaid Laws
3 Minute Read
Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Blog
April 14, 2021
The Current State of Pharmaceutical Price Transparency Reporting
2 Minute Read
What you need to know about navigating a patchwork of state policies, achieving operational readiness, and avoiding compliance risk.
March 11, 2021
Changes to Medicare Part D, Drug Rebate Program, OIG Final Rule
5 Minute Read
Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
February 16, 2021
New ASP Reporting Requirements, 340B Drug Pricing Program and Final Rule,...
4 Minute Read
Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
January 28, 2021
Five Steps to GTN Implementation Success
3 Minute Read
Pharmaceutical manufacturers can achieve GTN implementation success on day one of a new product launch by following these five best practices.
December 10, 2020
Gross-to-Net Roadmap to Launch
3 Minute Read
A comprehensive countdown of the Top 10 key gross-to-net (GTN) milestones for manufacturers about to launch their first commercial product.
October 26, 2020
GTN Analytics: Improve Visibility and Predictability of Your Forecasting and Accrual...
3 Minute Read
Data on Demand, GTN Reporting, Trends, and Metrics. Find out what's new in the latest ICyte Platform GTN Analytics release.
September 17, 2020
Additional Drug Reporting for NDA and ANDA Holders, FDA NSDE Structured...
2 Minute Read
Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
August 11, 2020
New Drug Pricing Executive Orders, Changes to 340B
2 Minute Read
Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.